X-LINKED RETINOSCHISIS
Clinical trials for X-LINKED RETINOSCHISIS explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINOSCHISIS trials appear
Sign up with your email to follow new studies for X-LINKED RETINOSCHISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial aims to save sight in boys and men with rare retinal disease
Disease control Recruiting nowThis study tests a gene therapy called ATSN-201 in males aged 6 and older with X-linked retinoschisis, a genetic eye condition that leads to vision loss. The therapy delivers a working copy of the RS1 gene to the retina. The trial has three parts: first, finding the right dose; s…
Matched conditions: X-LINKED RETINOSCHISIS
Phase: PHASE3 • Sponsor: Atsena Therapeutics Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New study aims to sharpen vision tests for retinal disease patients
Knowledge-focused Recruiting nowThis study is developing and testing new ways to measure vision and navigation skills in people with severe inherited retinal diseases like retinitis pigmentosa and Stargardt disease. Researchers will enroll 25 participants to see which tests are most reliable and practical. The …
Matched conditions: X-LINKED RETINOSCHISIS
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:58 UTC